{"provider": "google_genai", "model": "gemini-flash-lite-latest", "text": "{\"grade\": 0, \"reasoning\": \"The criterion requires the response to identify the significant loss of UK Patent Box relief on the residual profits as the primary commercial trade-off for the client. The candidate answer focuses entirely on recommending a specific hybrid structure (dual-entity with CSA/PSM) to achieve the profit shift goal while withstanding HMRC scrutiny. It discusses risks like DPT and R&D credit clawback, but it never explicitly mentions or quantifies the loss of UK Patent Box relief as the primary commercial trade-off associated with shifting residual profits out of the UK jurisdiction.\", \"criterion_id\": \"115d5474-f6c3-4eb3-b66f-6587d7f33846\"}", "usage": {"prompt_tokens": 2540, "completion_tokens": 163, "total_tokens": 2703}, "latency_s": 0.6792219170019962, "request_id": "M_2Uaf6BNOTQnsEPhvGb-Ag", "raw_response": null}